KLRS

Kalaris Therapeutics

85 hedge funds and large institutions have $294M invested in Kalaris Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$267K
Puts
$180K
Net Calls
Net Calls Change

Top Buyers

1 +$25.7M
2 +$17.1M
3 +$8.56M
4
GC
GMT Capital
Georgia
+$6.85M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.81M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$57.5M
2
$44M
3
$38.8M
4
$23M
5
$21.8M
6
$21M
7
$15.1M
8
$9.02M
9
$8.58M
10
$6.92M
11
$6.59M
12
$5.96M
13
$4.81M
14
$3.59M
15
$3.17M
16
$2.56M
17
$2.36M
18
$2.29M
19
$1.53M
20
$1.46M
21
$1.39M
22
$1.37M
23
$863K
24
$862K
25
$650K